361 related articles for article (PubMed ID: 2972301)
1. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Simon VC; Simon M
Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
[TBL] [Abstract][Full Text] [Related]
3. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
4. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
5. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
Drabu YJ; Blakemore PH
Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
7. Adverse effect of staphylococci slime on in vitro activity of glycopeptides.
Mathur T; Singhal S; Khan S; Upadhyay D; Fatma T; Rattan A
Jpn J Infect Dis; 2005 Dec; 58(6):353-7. PubMed ID: 16377866
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Ishag AJ; Durgham SM; Shibl AM
Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
[TBL] [Abstract][Full Text] [Related]
10. In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide.
Lopez S; Hackbarth C; Romanò G; Trias J; Jabes D; Goldstein BP
J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii21-4. PubMed ID: 15750033
[TBL] [Abstract][Full Text] [Related]
11. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
[TBL] [Abstract][Full Text] [Related]
12. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
[TBL] [Abstract][Full Text] [Related]
15. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
16. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
Nashev D; Toshkova K; Gavrilova V
Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
[TBL] [Abstract][Full Text] [Related]
17. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT
J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
[TBL] [Abstract][Full Text] [Related]
19. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
20. [Methicillin resistant Staphylococcus aureus and glycopeptides (vancomycin, teicoplanin): in vitro selection of resistance].
Serazin V; Mougeot C; Libert JM
Pathol Biol (Paris); 1994 Apr; 42(4):323-7. PubMed ID: 7808785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]